Cavalloni, G., Peraldo-Neia, C., Varamo, C., Chiorino, G., Sassi, F., Aglietta, M., & Leone, F. (2016). Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma. Oncotarget.
Chicago ZitierstilCavalloni, Giuliana, Caterina Peraldo-Neia, Chiara Varamo, Giovanna Chiorino, Francesco Sassi, Massimo Aglietta, und Francesco Leone. "Preclinical Activity of EGFR and MEK1/2 Inhibitors in the Treatment of Biliary Tract Carcinoma." Oncotarget 2016.
MLA ZitierstilCavalloni, Giuliana, et al. "Preclinical Activity of EGFR and MEK1/2 Inhibitors in the Treatment of Biliary Tract Carcinoma." Oncotarget 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.